|
Feb 24
|
Veracyte (VCYT) Q4 Earnings and Revenues Beat Estimates
|
|
Feb 24
|
Veracyte: Q4 Earnings Snapshot
|
|
Feb 24
|
Veracyte Announces Fourth Quarter and Full Year 2024 Financial Results
|
|
Feb 21
|
Is Veracyte Stock a Good Addition to Your Portfolio Right Now?
|
|
Feb 20
|
High Growth Tech Stocks To Watch In February 2025
|
|
Feb 14
|
Schrodinger Stock Scores IBD Rating Upgrade
|
|
Feb 14
|
New Data at ASCO GU Show Power of Veracyte’s Decipher Tests to Improve Patient Care and Its GRID Tool to Advance Prostate and Bladder Cancer Research
|
|
Feb 13
|
Best Momentum Stocks to Buy for February 13th
|
|
Feb 11
|
Veracyte Announces 17 Abstracts Demonstrating Its Decipher Tests’ Leadership in Urologic Cancers to Be Presented at the 2025 ASCO GU Symposium
|
|
Jan 3
|
Macroeconomic Woes, FX Headwind Drag NEOG Stock Down
|
|
Jan 3
|
Phibro Animal Health Gains 83% in a Year: What's Driving the Stock?
|
|
Jan 3
|
Should You Retain Labcorp Stock in Your Portfolio Right Now?
|
|
Sep 30
|
3 MedTech Stocks to Buy as Monetary Policy Eases
|
|
Sep 25
|
Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick
|
|
Sep 25
|
Looking for Medical Stocks? The Zacks Rank Can Help You Find Winners
|
|
Sep 6
|
Insider Sale: Chief Commercial Officer-CLIA John Leite Sells Shares of Veracyte Inc (VCYT)
|
|
Sep 5
|
Veracyte (VCYT) Up 9.2% Since Last Earnings Report: Can It Continue?
|
|
Sep 5
|
The Zacks Rank Explained: How to Find Strong Buy Medical Stocks
|
|
Sep 5
|
Should You Continue to Retain ABT Stock in Your Portfolio Now?
|
|
Sep 4
|
Veracyte Appoints Brent Shafer and Tom Miller, Ph.D., to Its Board of Directors
|